Search





Search





Markets
/
Stocks
/
mrvi
/

Maravai LifeSciences Holdings Inc

MRVI

Add to Watchlist

6.570USD

-0.180-2.67%

Close 07-31 16:00（ET）Quotes delayed by 15 min

1.70BMarket Cap

LossP/E TTM

Maravai LifeSciences Holdings Inc

6.570

-0.180-2.67%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

MRVI Cash Flow Statement

You can access the annual and quarterly cash flow statements of Maravai LifeSciences Holdings Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2019Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

192.28%8.66M

-55.54%-22.77M

-215.33%-15.15M

-158.88%-10.27M

-10.90%-9.39M

-287.91%-14.64M

-7.27%13.14M

-9.17%17.43M

-109.95%-8.47M

-92.16%7.79M

-87.13%14.17M

-88.32%19.19M

-47.58%85.07M

70.78%99.33M

4.26%110.06M

-1.00%164.28M

323.48%162.30M

-17.07%58.17M

--105.56M

--165.94M

--38.33M

658.64%70.14M

--9.24M

Net income from continuing operations

87.93%-6.38M

-35.53%-63.02M

74.39%-45.06M

-381.90%-69.84M

-133.04%-52.85M

57.72%-46.49M

-1065.11%-175.96M

-21.34%-14.49M

-1582.49%-22.68M

-225.80%-109.98M

-115.15%-15.10M

-107.62%-11.94M

-100.92%-1.35M

-30.75%87.43M

-24.61%99.65M

16.52%156.72M

94.61%146.86M

772.33%126.24M

--132.18M

--134.50M

--75.47M

365.54%14.47M

---5.45M

Operating gains losses

-56.20%11.98M

104.85%54.16M

-92.17%13.18M

199.76%43.61M

98.83%27.34M

103.68%26.44M

1184.96%168.28M

23.30%14.55M

26.09%13.75M

29.42%12.98M

32.16%13.10M

32.43%11.80M

17.84%10.91M

-19.42%10.03M

23.83%9.91M

14.41%8.91M

6.70%9.26M

110.06%12.45M

--8.00M

--7.79M

--8.68M

-10.70%5.92M

--6.63M

Deferred tax

----

-281.82%-20.00K

----

-100.00%11.00K

100.00%0.00

10807.86%764.75M

-159.91%-5.53M

-121.44%-2.76M

-111.50%-1.52M

-59.86%7.01M

-17.75%9.23M

99.29%12.86M

12.39%13.22M

516.95%17.47M

--11.23M

--6.45M

--11.76M

-261.43%-4.19M

---1.16M

Other non-cash items

854.22%2.15M

-70.73%1.61M

39.68%2.99M

1114.62%7.89M

-76.64%225.00K

100.82%5.51M

181.84%2.14M

119.04%650.00K

-64.43%963.00K

-14528.41%-668.32M

121.58%760.00K

-926.39%-3.41M

211.95%2.71M

13.09%4.63M

-53.66%-3.52M

-52.20%413.00K

56.29%-2.42M

-55.47%4.10M

---2.29M

--864.00K

---5.53M

3934.65%9.20M

--228.00K

Change in working capital

-206.10%-5.83M

-94.02%-19.43M

-16.97%4.82M

-49.06%1.14M

151.59%5.49M

-520.93%-10.01M

-32.35%5.80M

-87.92%2.24M

-115.57%-10.64M

115.09%2.38M

186.11%8.57M

266.71%18.55M

929.58%68.34M

84.89%-15.76M

72.25%-9.96M

-179.73%-11.13M

84.83%-8.24M

-393.29%-104.31M

---35.87M

--13.96M

---54.32M

323.72%35.57M

--8.39M

-Change in receivables

-177.89%-7.91M

73.90%-2.96M

-48.02%5.12M

124.79%501.00K

-43.19%10.16M

-29.14%-11.35M

206.41%9.84M

-126.73%-2.02M

-78.30%17.88M

0.18%-8.79M

-44.94%3.21M

6674.78%7.56M

3817.05%82.41M

82.92%-8.80M

-66.89%5.83M

-100.33%-115.00K

96.87%-2.22M

-331.37%-51.54M

--17.62M

--34.34M

---70.81M

3105.18%22.28M

--695.00K

-Change in inventory

-92.65%33.00K

845.57%3.09M

188.76%1.35M

313.85%3.11M

-45.24%449.00K

114.97%327.00K

-1.74%-1.52M

-90.26%751.00K

124.24%820.00K

-111.33%-2.18M

35.34%-1.50M

188.60%7.71M

-381.68%-3.38M

311.03%19.27M

72.98%-2.31M

-85.72%-8.70M

108.70%1.20M

169.83%4.69M

---8.56M

---4.69M

---13.81M

-735.29%-6.71M

--1.06M

-Change in prepaid expenses

-36.06%1.43M

18.57%1.18M

142.82%1.07M

-1338.19%-2.86M

206.99%2.24M

-84.38%996.00K

-87.38%439.00K

-100.93%-199.00K

103.17%730.00K

138.64%6.38M

113.22%3.48M

269.42%21.29M

-1014.26%-23.01M

-757.93%-16.50M

-2622.13%-26.32M

-180.00%-12.57M

533.22%2.52M

57.71%-1.92M

---967.00K

---4.49M

---581.00K

-329.76%-4.55M

--1.98M

-Change in other current assets

----

--181.00K

----

100.00%0.00

---13.00K

-Change in other current liabilities

97.50%-203.00K

-210.33%-1.89M

-144.46%-1.32M

-89.37%-7.30M

-256.28%-8.11M

26.68%-610.00K

45.25%-542.00K

-71.80%-3.86M

80.48%-2.28M

-26.83%-832.00K

-171.79%-990.00K

-162.19%-2.25M

-52.89%-11.66M

98.93%-656.00K

103.21%1.38M

130.92%3.61M

-119.20%-7.63M

-520.74%-61.29M

---42.97M

---11.68M

--39.73M

1654.75%14.57M

---937.00K

Cash from non-recurring investing activities

Cash from operating activities

192.28%8.66M

-55.54%-22.77M

-215.33%-15.15M

-158.88%-10.27M

-10.90%-9.39M

-287.91%-14.64M

-7.27%13.14M

-9.17%17.43M

-109.95%-8.47M

-92.16%7.79M

-87.13%14.17M

-88.32%19.19M

-47.58%85.07M

70.78%99.33M

4.26%110.06M

-1.00%164.28M

323.48%162.30M

-17.07%58.17M

--105.56M

--165.94M

--38.33M

658.64%70.14M

--9.24M

Investing cash flow

Net cash from continuing investing activities

-1.42%4.44M

-54.35%2.11M

-67.34%2.93M

-53.51%2.87M

6.06%4.50M

-64.11%4.63M

-42.27%8.96M

-74.69%6.18M

2752.50%4.24M

152.55%12.90M

139.99%15.52M

1370.50%24.43M

-105.82%-160.00K

-9.77%5.11M

386.61%6.47M

-63.36%1.66M

-1.29%2.75M

-36.02%5.66M

--1.33M

--4.53M

--2.78M

85.90%8.85M

--4.76M

Capital expenditures

-15.24%4.44M

-66.70%2.11M

-69.49%2.93M

-69.92%2.87M

-7.59%5.24M

-62.21%6.35M

-39.40%9.59M

-61.88%9.55M

-28.00%5.67M

170.34%16.80M

144.73%15.83M

1408.67%25.06M

186.32%7.87M

9.75%6.21M

386.61%6.47M

-63.36%1.66M

-17.53%2.75M

-36.02%5.66M

--1.33M

--4.53M

--3.33M

85.90%8.85M

--4.76M

Net cash flow from disposal of fixed assets

-1.42%4.44M

-48.83%2.11M

-63.24%2.93M

-53.51%2.87M

6.06%4.50M

-67.98%4.13M

-48.72%7.96M

-74.69%6.18M

2752.50%4.24M

152.55%12.90M

139.99%15.52M

1370.50%24.43M

-105.82%-160.00K

-9.77%5.11M

386.61%6.47M

-63.36%1.66M

-1.29%2.75M

-36.02%5.66M

--1.33M

--4.53M

--2.78M

85.90%8.85M

--4.76M

Net cash flow from intangible asset transactions

----

--500.00K

--1.00M

----

--0.00

Net cash flow from business transactions

100.00%0.00

--0.00

---362.00K

---18.63M

--0.00

-100.00%0.00

100.00%0.00

-100.00%0.00

--109.00K

70.80%-69.73M

---133.00K

-99.48%620.00K

--0.00

---238.84M

--0.00

--119.96M

----

--0.00

Net cash flow from other investing activities

--0.00

100.00%0.00

--0.00

----

---300.00K

----

100.00%0.00

----

--159.00K

---159.00K

---13.28M

----

Cash from non-current investing activities

Net cash flow from investing activities

80.82%-4.44M

57.13%-2.11M

67.34%-2.93M

47.65%-3.24M

-444.98%-23.13M

61.78%-4.93M

42.27%-8.96M

74.41%-6.18M

93.91%-4.24M

30.33%-12.90M

-165.44%-15.52M

-1354.36%-24.16M

71.14%-69.73M

-227.09%-18.52M

-104.93%-5.85M

63.36%-1.66M

-8577.59%-241.58M

36.02%-5.66M

--118.63M

---4.53M

---2.78M

-85.90%-8.85M

---4.76M

Financing cash flow

Cash flow from continuous financing activities

-1027.06%-55.23M

99.23%-1.82M

-1119.65%-8.25M

-772.81%-1.53M

-775.00%-4.90M

-50352.98%-236.19M

3.32%809.00K

100.53%228.00K

97.08%-560.00K

100.71%470.00K

102.09%783.00K

0.64%-43.13M

52.60%-19.21M

-34.95%-66.12M

26.99%-37.44M

-27.20%-43.41M

-68.44%-40.52M

-198.06%-49.00M

---51.28M

---34.13M

---24.06M

113461.36%49.97M

--44.00K

Net cash flow from debt Issuance/repayment

-3228.58%-51.36M

99.66%-790.00K

-2.63%-1.56M

-2.59%-1.55M

-2.52%-1.54M

-15182.29%-229.54M

-2.43%-1.52M

-5.75%-1.51M

-10.66%-1.50M

-10.44%-1.50M

-9.12%-1.48M

-4.85%-1.43M

0.00%-1.36M

9.33%-1.36M

-100.82%-1.50M

---1.50M

28121.65%183.82M

---656.00K

Net cash flow from common stock issuance/repurchase

----

--300.95M

----

Proceeds from stock option exercised by employees

----

865.45%4.61M

684.21%111.00K

146.43%13.00K

-230.22%-4.73M

-71.51%-602.00K

-106.09%-19.00K

-107.95%-28.00K

-330.33%-1.43M

-196.16%-351.00K

-57.26%312.00K

-34.45%352.00K

-145.87%-333.00K

-3.95%365.00K

134.73%730.00K

19.87%537.00K

27.37%726.00K

18.38%380.00K

--311.00K

--448.00K

--570.00K

--321.00K

----

Net cash flow from other financing activities

-381.16%-3.87M

6.66%-5.64M

-389.61%-6.80M

-100.00%0.00

-42.18%1.38M

-360.31%-6.05M

20.10%2.35M

104.19%1.76M

113.58%2.38M

103.57%2.32M

105.31%1.96M

1.24%-42.06M

56.09%-17.52M

-36.03%-65.13M

26.52%-36.81M

-28.76%-42.59M

-72.47%-39.89M

84.81%-47.88M

---50.09M

---33.08M

---23.13M

-45117.29%-315.12M

--700.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

-1027.06%-55.23M

99.23%-1.82M

-1119.65%-8.25M

-772.81%-1.53M

-775.00%-4.90M

-50352.98%-236.19M

3.32%809.00K

100.53%228.00K

97.08%-560.00K

100.71%470.00K

102.09%783.00K

0.64%-43.13M

52.60%-19.21M

-34.95%-66.12M

26.99%-37.44M

-27.20%-43.41M

-68.44%-40.52M

-198.06%-49.00M

---51.28M

---34.13M

---24.06M

113461.36%49.97M

--44.00K

Net cash flow

Beginning cash balance

-32.73%216.89M

-57.87%243.57M

-52.91%269.91M

-49.25%285.05M

-43.93%322.40M

-0.25%578.16M

-1.21%573.17M

-10.60%561.69M

-9.04%574.96M

-6.13%579.61M

5.36%580.18M

45.61%628.27M

14.67%632.14M

12.69%617.45M

46.96%550.68M

74.21%431.47M

133.41%551.27M

338.73%547.90M

--374.71M

--247.68M

--236.18M

520.81%124.88M

--20.12M

Current period cash flow changes

-36.48%-50.97M

89.57%-26.68M

-628.14%-26.33M

-231.93%-15.15M

-181.41%-37.35M

-5408.46%-255.76M

973.20%4.99M

123.87%11.48M

-243.36%-13.27M

-131.60%-4.64M

-100.86%-571.00K

-140.35%-48.10M

96.77%-3.87M

335.45%14.69M

-61.45%66.77M

-6.16%119.21M

-1142.58%-119.80M

-96.97%3.37M

--173.19M

--127.03M

--11.49M

2328.05%111.30M

--4.58M

Effect of exchange rate changes

-58.90%30.00K

--14.00K

---8.00K

---111.00K

--73.00K

----

100.00%0.00

-100.00%0.00

-377.08%-133.00K

--32.00K

--6.00K

--7.00K

-12.73%48.00K

--55.00K

Ending cash balance

-41.79%165.92M

-32.73%216.89M

-57.87%243.57M

-52.91%269.91M

-49.25%285.05M

-43.93%322.40M

-0.25%578.16M

-1.21%573.17M

-10.60%561.69M

-9.04%574.96M

-6.13%579.61M

5.36%580.18M

45.61%628.27M

14.67%632.14M

12.69%617.45M

46.96%550.68M

74.21%431.47M

133.41%551.27M

--547.90M

--374.71M

--247.68M

856.21%236.18M

--24.70M

Free cash flow

128.91%4.23M

-18.56%-24.88M

-609.90%-18.08M

-266.72%-13.14M

-3.49%-14.63M

-132.96%-20.99M

313.43%3.54M

234.37%7.88M

-118.30%-14.13M

-109.67%-9.01M

-101.60%-1.66M

-103.61%-5.87M

-51.61%77.21M

77.36%93.12M

-0.61%103.59M

0.75%162.62M

355.95%159.56M

-14.33%52.51M

--104.23M

--161.41M

--34.99M

1266.49%61.29M

--4.49M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Maravai LifeSciences Holdings Inc Generate?



Maravai LifeSciences Holdings Inc generated -57.57M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Maravai LifeSciences Holdings Inc's Operating Cash Flow Change Year Over Year?



Maravai LifeSciences Holdings Inc's operating cash flow increased by -871.24% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Maravai LifeSciences Holdings Inc Spend on Capital Expenditures?



Maravai LifeSciences Holdings Inc spent 13.15M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Maravai LifeSciences Holdings Inc's Financing Cash Flow Changed?



Maravai LifeSciences Holdings Inc used -16.50M in financing activities in the latest quarter.

What is free cash flow and why does it matter for MRVI?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Maravai LifeSciences Holdings Inc’s free cash flow in the latest quarter?



Free cash flow was -70.72M reflecting a -198.49% change from the previous year.